Use of ASCO/Conquer Cancer®, the ASCO Foundation Name Approval Form Instructions   
 

All names, trademarks, service marks, brands, logos, designs, trade dress, slogans, and other designations of the ASCO Entities, and all of their related products and services (collectively “ASCO Trademark(s)”) are the sole and exclusive property of ASCO. The use of an ASCO Trademark is strictly prohibited without the express, written permission of ASCO. The mere execution of an advertising and/or exhibit agreement does not constitute written permission.* This form must be submitted for review and prior approval of the proposed use through the Exhibitor Resource Center no later than Wednesday, April 24.    

All materials (including but not limited to promotional materials, exhibit booth banners or decorations, billboards, airport advertising, and other signage) must comply with the Policies for Exhibitors and Other Organizations at ASCO Meetings.    

Notwithstanding the above, Exhibitors and Other Organizations at ASCO Meetings may use ASCO’s plain text name in (i) reference citations or (ii) as required in the disclaimer for signage and the disclaimer in other materials associated with ancillary events as set forth in the Ancillary Event Space Guidelines.

Additionally, Exhibitors at a Meeting that are advertising their attendance as Exhibitors at the Meeting are permitted to use certain ASCO Trademarks. Such Exhibitor use is subject to the following permissions and restrictions:
 
  • The plain text name of the ASCO meeting or symposia may be mentioned one (1) time only in each communication for identification purposes and should be referred to as “20xx ASCO® Annual Meeting”, “20xx [insert name of Symposium]” or any other official name for an individual meeting as decided by ASCO in all advertising except Out-ofHome advertising. The use of ASCO logos is prohibited for this purpose.
  • Out-of-Home advertising (i.e., billboards and airport signage) cannot mention ASCO, the name, dates, or venue of the ASCO meeting.
  • Advertisers should use the full name of the meeting 20XX ASCO Annual Meeting wherever possible.  Use of “ASCO 20xx” and/or “ASCOXX” is rarely permitted and must be specifically approved by ASCO, for each instance.
  • Use of ASCO related logos is prohibited unless part of “Exhibiting At” graphics provided to Exhibitors by ASCO in the Exhibitor Resource Center.
  • None of the ASCO Entity names may (1) be part of a title or heading on any materials, (2) be prominently featured or listed first in any materials, or (3) used in a way that suggests or implies the endorsement or sponsorship of an ASCO Entity in any way.
  • ASCO Trademarks, including the mark “ASCO”, may only be used in web URLs and links as slugs or subdirectories in this format - www.companyname.com/ascoXX.
  • Webpage titles, paid searches, Google Ads, mobile applications, or similar online functionality containing ASCO Trademarks are prohibited.
  • Use of ASCO in hashtags or other social media functions other than the official meeting hashtag may not be used in a way that violates the Policy for Exhibitors and Other Organizations at ASCO Meetings or otherwise detracts from the scientific nature of the applicable meeting.
  • Marketing can NOT include information regarding a session held by ASCO as part of the official meeting program, including date, time, location of, link to a session or poster session.  It can include the abstract title or track.  
The use of any ASCO Trademark pursuant to an above exception in any materials, websites, or applications will be subject to review by ASCO for consistency and compliance. 

For further information about use of ASCO’s names and trademarks or for any questions, send an email to exhibits@asco.org or contact ASCO Exhibits at 571-483-1300. Violations of this trademark policy may result in exhibitors being assessed licensing fees, in addition to other remedies available to ASCO. If you are interested in licensing ASCO content, please contact licensing@asco.org. 

The Use of ASCO/ Conquer Cancer®, the ASCO Foundation Name Approval Form, and the accompanying proof of the piece must be submitted through the Exhibitor Resource Center by Wednesday, April 24.  Decisions about requested uses will be sent via email within five (5) business days of receipt.  Please upload the file of your sample piece when submitting the form. For print and digital communication, the name must be correctly referenced as Conquer Cancer®, the ASCO Foundation.  

*Exhibitors who have purchased the attendee mailing list through InFocus do not need to submit this form for mailing list use in addition to the separate review process in place for those items.    

Use of ASCO Email/Social Media/Web Banner Image 

ASCO is offering exhibitors the opportunity to promote their presence at the 2024 ASCO Annual Meeting in email signatures, social media, and with the use of an ASCO-approved web banner. These images are the only approved use of ASCO’s logo. The files may not be altered in any way. Please select the appropriate file below.   

Email Banner 
Web Banner 
X (formerly Twitter) 
LinkedIn 
Facebook and Instagram    

Questions? 
Please contact Eileen McGill, ASCO Exhibit Operations Management at eileen.mcgill@spargoinc.com or 703-679-3969.